Clinical manifestations in individuals with recent diagnosis of HTLV type I infection

Journal of Clinical Virology

Volumn 51, Issue 1, 2011, Pages 54-58

  Poetker, Shelene K W ^a,b,c   Porto, Aurelia F ^a   Giozza, Silvana P ^a   Muniz, Andre L ^a   Caskey, Marina F ^b   Carvalho, Edgar M ^a,d   Glesby, Marshall J ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais CNPq MCT   (Brazil)

Author keywords

Clinical manifestations; HTLV 1; Natural history; Neurologic manifestations; Neuropathy

Indexed keywords

ARTHRALGIA; ARTICLE; BLOOD DONOR; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NOCTURIA; PARESTHESIA; PHOTOPHOBIA; PRIORITY JOURNAL; RUNNING;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ARTHROPATHY, NEUROGENIC; BRAZIL; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PERIODONTAL DISEASES; SEX FACTORS; SJOGREN'S SYNDROME; UVEITIS;

EID: 79953745828     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.02.004     Document Type: Article

References (42)

1. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005, 24:6058-6068.
2. Vrielink H., Reeskink H.W. HTLV-1/2 prevalence in different geographic locations. Transfus Med Rev 2004, 18(1):46-57.
3. Poiesz B.J., Ruscetti F.W., Gaxdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980, 77:7415-7419.
4. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., et al. The risk of development of HTLV-1-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-1. J Acquir Immune Defic Syndr 1990, 3(11):1096-1101.
5. Orland J.R., Engstrom J., Fridey J., Sacher R.A., Smith J.W., Nass C., et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 2003, 61:1588-1594.
6. Cleghorn F.R., Manns A., Falk R., Hartge P., Hanchard B., Jack N., et al. Effect of human T-lymphotropic virus type 1 infection on non-Hodkin's lymphoma incidence. J Natl Cancer Inst 1995, 87:1009-1014.
7. Mahieux R., Gessain A. HTLV-1 and associated adult T-cell leukemia/lymphoma. Rev Clin Exp Hematol 2003, 7(4):336-361.
8. Verdonck K., Gondzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Inf Dis 2007, 7:266-281.
9. Mochizuki M., Watanabe T., Yamaguchi K., Tajima K., Yoshimura K., Nakashima S., et al. An uveitis associated with human T-lymphotropic virus type-1 (HTLV-1): seroepidemiological, clinical, and virological studies. J Infect Dis 1992, 166:943-944.
10. Takahashi T., Takase H., Urano T. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow up. Ocul Immunol Inflamm 2000, 8:235-241.
11. Buggage R. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr Opin Ophthalmol 2003, 14:420-425.
12. Morgan O.S., Rodgers-Johnson P., Mora C., Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989, 2(8673):1184-1187.
13. Osame M., Nakagawa M., Umehara F., Ijichi S., Moritoyo T., Higuchi I., et al. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-1 associated myelopathy (HAM/TSP) and other diseases associated to HTLV. J Neurovirol 1997, 3(Suppl. 1):S50-S51.
14. Nishioka K., Maruyma I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthopathy associated with HTLV-1. Lancet 1989, 1:441.
15. Murphy E.L., Wang B., Sacher R.A., Fridey J., Smith J.W., Nass C.C., et al. Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-1 and HTLV-II infection. Emerg Infect Dis 2004, 10:109-116.
16. Ferraz-Chaoui A.K., Atta A.M., Atta M.L.S., Galvao-Castro B., Santiago M.B. Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1. Rheumatol Int 2010, 30:775-778.
17. Castro N., Oliveira P., Freitas D., Rodrigues W., Muniz A., Carvalho E. Erectile dysfunction and HTLV-1 infection: a silent problem. Int J Impot Res 2005, 17:364-369.
18. Castro N.M., Freitas D.M., Rodrigues W., Muniz A., Oliveira P., Carvalho E.M. Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals. Neurourology 2007, 33(2):238-245.
19. Biswas H.H., Engstrom J.W., Kaidarova Z., Garratty G., Gibble J.W., Newman B.H., et al. Neurologic abnormalities in HTLVA-1- and HTLV-2-infected individuals without overt myelopathy. Neurology 2009, 73:781-789.
20. Leite A.C.C., Mendonca G.A.S., Andrada-Serpa M.J., Nascimento O.J.M., Araujo A.Q.C. Neurological manifestations in HTLV-1-infected blood donors. J Neurol Sci 2003, 214:49-56.
21. Leite A.C., Silva M.T., Alamy A.H., Afonso C.R.A., Lima M.A.D., Andrada-Serpa M.J. Peripheral neuropathy in HTLV-1 infected individuals without tropical spastic paraparesis/HTLV-1-associated myelopathy. J Neurol 2004, 251(7):877-881.
22. Grindstaff P., Gruener G. The peripheral nervous system complications of HTL-1 myelopathy (HAM/TSP) syndromes. Semin Neurol 2005, 25(3):315-327.
23. Caskey M.F., Morgan D.J., Porto A.F., Giozza S.P., Muniz A.L., Orge G.O., et al. Clinical manifestations associated with HTLV type 1 infection: a cross-sectional study. AIDS Res Hum Retroviruses 2007, 23(3):365-371.
24. Galvao-Castro B., Loures L., Rodrigues L.G., Sereno A., Ferreira Junior O.C., Franco L.G., et al. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 1997, 37:242.
25. Dourado I., Alcantara L.C., Barreto M.L., da Gloria Teixeira M., Galvao-Castro B. HTLV-1 in the general population of Salvador, Brazil - a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 2003, 34(5):527-531.
26. Osame M. Review of WHO Kagoshima meeting diagnostic guidelines form HAM/TSP. Human retrovirology: HTLV 1990, 191-197. Raven Press, New York. W. Blattner (Ed.).
27. Garlet G.P., Giozza S.P., Silveira E.M., Claudino M., Santos S.B., Avila-Campos M.J., et al. Clin Infect Dis 2010, 50(3):e11-e18.
28. Oliveira P., Castro N.M., Carvalho E.M. Urinary and sexual manifestations of patients infected by HTLV-1. Clinics 2007, 62(2):191-196.
29. Castro N.M., Rodrigues W., Freitas D.M., Muniz A., Oliveira P., Carvalho E.M. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-1 carriers. Adult Urol 2007, 69(5):813-818.
30. Oliveira P., Castro N.M., Muniz A.L., Tanajura D., Brandao J.C., Porto A.F., et al. Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder. Urology 2010, 75(5):1100-1103.
31. Goncalves D.U., Guedes A.C., Proietti A.B., Martins M.L., Proietti F.A., Lambertucci J.R., et al. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1. Am J Trop Med Hyg 2003, 68(5):562-565.
32. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002, 186(Suppl. 2):S187-S192.
33. Cooper S.A., Schim van der Loeff M., Taylor G.P. The neurology of HTLV-1 infection. Pract Neurol 2009, 9:16-26.
34. Nascimento M.C.F., Primo J., Bittencourt A., Siqueira I., Oliveira M.d.F., Meyer R., et al. Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Clin Exp Immunol 2009, 156:455-462.
35. Yakova M., Lezin A., Dantin F., Lagathu G., Olindo S., Jean-Baptiste G., et al. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease. Retrovirology 2005, 1:2-4.
36. Silva M.T.T., Harab R.C., Leite A.C., Schor D., Araujo A., Andrade-Serpa M.J., et al. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin Infect Dis 2007, 44:689-692.
37. Carvalho E.M., Bacellar O., Porto A.F., Braga S., Galvao-Castro B., Neva F. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr 2001, 27:1-6.
38. Santos S.B., Porto A.F., Muniz A.L., de Jesus A.R., Magalhaes E., Melo A., et al. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-1 asymptomatic carriers. BMC Infect Dis 2004, 4-7.
39. Guerreiro J.B., Porto M.A.F., Santos S.B., Lacerda L., Ho J.L., Carvalho E.M. Spontaneous neutrophil activation in HTLV-1 infected patients. Braz J Infect Dis 2005, 9(6):510-514.
40. Mota A., Nunes C., Melo A., Romeo M., Boasorte N., Dourado I., et al. A case-control study of HTLV-infection among blood donors in Salvador, Bahia, Brazil - associated risk factors and trend towards declining prevalence. Rev Bras Hematol Hemoter 2006, 28(2):120-126.
41. Bagnato F., Butman J.A., Mora C.A., Gupta S., Yamano Y., Tasciyan T.A., et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol 2005, 11:525-534.
42. Morgan D.J., Caskey M.F., Abbehusen C., Oliveira-Filho J., Araujo C., Porto A.F., et al. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-1 carriers and do not discriminate from HAM/TSP. AIDS Res Hum Retroviruses 2007, 23:1499-1504.